A Study to Investigate the Safety and Efficacy of a Recombinant Human Parathyroid Hormone, for the Treatment of Adults With Hypoparathyroidism (RELAY)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
NPS Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01268098
First received: December 28, 2010
Last updated: October 1, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 21, 2012